Ocular manifestations as the first symptom or manifestation of covid-19: a literature review Review article

Article Sidebar

PDF PDF (Język Polski)


Published: Sep 30, 2024
DOI: https://doi.org/10.24292/01.OT.230924
Keywords:
COVID-19, ocular manifestations, eye diseases, first symptoms, SARS-CoV-2

Main Article Content

Katarzyna Ulaszewska
"Orbita”, Medical Center in Warsaw
https://orcid.org/0000-0002-2941-4878
Alan Chamernik
"Orbita”, Medical Center in Warsaw
https://orcid.org/0009-0009-0987-084X
Katarzyna Różycka
1. “Orbita”, Medical Center in Warsaw. 2. Faculty of Medicine, Lazarski University in Warsaw
https://orcid.org/0009-0000-4144-0588
Krystian Bakalarski
1. “Orbita”, Medical Center in Warsaw. 2. Faculty of Medicine, Lazarski University in Warsaw
https://orcid.org/0009-0006-1425-1590
Małgorzata Różycka
1. “Orbita”, Medical Center in Warsaw. 2. Faculty of Medicine, Lazarski University in Warsaw
https://orcid.org/0009-0001-3643-0948
Piotr Nesterowicz
1. “Orbita”, Medical Center in Warsaw. 2. Faculty of Medicine, Lazarski University in Warsaw
https://orcid.org/0009-0009-1999-6956
Radosław Różycki
1. Ophthalmology Clinic, Military Institute of Aviation Medicine, Warsaw. 2. "Orbita”, Medical Center in Warsaw
https://orcid.org/0000-0001-7040-026X

Abstract

The aim of this review is to analyze the available scientific literature on the impact of COVID-19 on eye health. A systematic literature review was conducted using medical databases. The focus was on publications regarding the ophthalmic manifestations of COVID-19, analyzing reported symptoms and pathophysiological mechanisms. The literature analysis revealed that COVID-19 can manifest as various eye conditions, such as conjunctivitis, keratopathy, uveitis, retinopathy, and optic neuropathy. Additionally, cases related to retinal microangiopathy and thrombosis have been described, which can lead to permanent vision loss. These findings suggest that SARS-CoV-2 may directly or indirectly affect various structures of the organ of vision through inflammatory and thrombotic mechanisms.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Ulaszewska K, Chamernik A, Różycka K, Bakalarski K, Różycka M, Nesterowicz P, Różycki R. Ocular manifestations as the first symptom or manifestation of covid-19: a literature review. Ophthatherapy [Internet]. 2024Sep.30 [cited 2024Nov.23];00. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/3121
Issue
Ahead of print
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Khanna RC, Cicinelli MV, Gilbert SS et al. COVID-19 pandemic: Lessons learned and future directions. Indian J Ophthalmol. 2020; 68(5): 703-10.
2. Ulaszewska K, Jodczyk AM, Długołęcki P et al. Factors Associated with Willingness to Receive a COVID-19 Vaccine in Adult Polish Population – A Cross-Sectional Survey. Vaccines. 2022; 10(10): 1715.
3. Braczkowska B, Kowalska M, Braczkowski R et al. Determinants of vaccine hesitancy. Przegl Epidemiol. 2017; 71(2): 227-36.
4. Jodczyk AM, Kasiak PS, Adamczyk N et al. PaLS Study: Tobacco, Alcohol and Drugs Usage among Polish University Students in the Context of Stress Caused by the COVID-19 Pandemic. Int J Environ Res Public Health. 2022; 19(3): 1261.
5. Nasiri N, Sharifi H, Bazrafshan A et al. Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis. J Ophthalmic Vis Res. 2021; 16(1): 103-12.
6. Sen M, Honavar SG, Sharma N et al. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J Ophthalmol. 2021; 69(3): 488.
7. Shah KK, Venkatramani D, Majumder PD. A case series of presumed fungal endogenous endophthalmitis in post COVID-19 patients. Indian J Ophthalmol. 2021; 69(5): 1322.
8. Vabret A, Mourez T, Dina J et al. Human Coronavirus NL63, France. Emerg Infect Dis. 2005; 11(8): 1225-9.
9. Loon SC, Teoh SCB, Oon LLE et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004; 88(7): 861.
10. Alfonso SA, Fawley JD, Alexa Lu X. Conjunctivitis. Prim Care. 2015; 42(3): 325-45.
11. Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013; 310(16): 1721-9.
12. Sindhuja K, Lomi N, Asif MI et al. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J Ophthalmol. 2020; 68(8): 1546.
13. Chen L, Deng C, Chen X et al. Ocular manifestations and clinical characteristics of 535 cases of COVID‐19 in Wuhan, China: a cross‐sectional study. Acta Ophthalmologica. 2020; 98(8): e951.
14. Nayak B, Poddar C, Panigrahi MK et al. Late manifestation of follicular conjunctivitis in ventilated patient following COVID-19 positive severe pneumonia. Indian J Ophthalmol. 2020; 68(8): 1675.
15. Loffredo L, Pacella F, Pacella E et al. Conjunctivitis and COVID‐19: A meta‐analysis. J Med Virol. 2020; 92(9): 1413-4.
16. Fernández Alcalde C, Granados Fernández M, Nieves Moreno M et al. COVID-19 ocular findings in children: a case series. World J Pediatr. 2021; 17(3): 329-34.
17. Pérez-Chimal LG, Cuevas GG, Di-Luciano A et al. Ophthalmic manifestations associated with SARS-CoV-2 in newborn infants: a preliminary report. J AAPOS. 2021; 25(2): 102-4.
18. Zhang Y, Stewart JM. Retinal and choroidal manifestations of COVID-19. Curr Opin Ophthalmol. 2021; 32(6): 536-40.
19. Abbinante G, Plaitano C, Gallo FG et al. A case of retinal vascular involvement in a 6-year-old patient with Covid-19. Eur J Ophthalmol. 2022; 32(4): NP1-5.
20. Arkan İ, Demir ST, Livan EH et al. Ocular Manifestations of Multisystem Inflammatory Syndrome in Children with COVID-19. Pediatr Infect Dis J. 2021; 40(9): e356-8.
21. Otaif W, Al Somali AI, Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report. Am J Ophthalmol Case Rep. 2020; 20: 100917.
22. Méndez Mangana C, Barraquer Kargacin A, Barraquer RI. Episcleritis as an ocular manifestation in a patient with COVID‐19. Acta Ophthalmol. 2020; 98(8): e1056-7.
23. Alnahdi MA, Alkharashi M. Ocular manifestations of COVID-19 in the pediatric age group. Eur J Ophthalmol. 2023; 33(1): 21-28.
24. Koh S, Rhee MK. COVID-19 and Dry Eye. Eye Contact Lens. 2021; 47(6): 317-22.
25. Kaur K, Gurnani B, Nayak S et al. Digital Eye Strain- A Comprehensive Review. Ophthalmol Ther. 2022; 11(5): 1655-80.
26. Krolo I, Blazeka M, Merdzo I et al. Mask-Associated Dry Eye During COVID-19 Pandemic-How Face Masks Contribute to Dry Eye Disease Symptoms. Med Arch. 2021; 75(2): 144-8.